Whilst GLP-1 receptor agonists such as semaglutide and liraglutide have demonstrated significant effects on blood glucose control and body weight, there is currently no established evidence that these medications directly treat hot flashes
The court is still addressing issues involving general causation and preemption, and no bellwether trials have been scheduled
J Neurosci 31(17):65876594 Hansen HH, Barkholt P, Fabricius K, Jelsing J, Terwel D, Pyke C, Knudsen LB, Vrang N (2016) The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
On this view, exenatide and lixisenatide cross the blood-brain barrier readily and showed positive effects in Parkinsons disease
Combining Weight Loss Injections with Lifestyle Changes for Optimal Results Weight loss injections may be extremely effective on their own, but optimal and long-term results occur when they are used in conjunction with significant lifestyle adjustments